tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Income Statement

Compare
140 Followers

MiNK Therapeutics Income Statement

Last quarter (Q3 2024), MiNK Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MiNK Therapeutics's net income was $-1.81M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 2.70B$ 0.00$ 0.00$ 689.63K
Gross Profit
$ -204.62K$ -28.24B$ -28.36B$ -55.06K$ 689.63K
Operating Expenses
$ 22.92M$ 30.95M$ 18.61M$ 10.80M$ 23.48M
Depreciation and Amortization
$ 204.62K$ 121.75K$ 77.96K$ 55.06K$ 36.82K
EBITDA
$ -22.25M$ -30.83M$ -27.70M$ -13.74M$ -22.20M
Operating Income
$ -22.92M$ -30.95M$ -28.36M$ -14.64M$ -22.28M
Other Income/Expenses
$ 463.25K$ 2.96M$ -1.85M$ -1.60M$ -1.52M
Pretax Income
$ -22.46M$ -27.99M$ -30.21M$ -16.24M$ -23.80M
Net Income
$ -22.46M$ -24.78M$ -23.11M$ -15.68M$ -25.91M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.65$ -0.74$ -0.69$ -0.47$ -0.78
Diluted EPS
$ -0.65$ -0.74$ -0.69$ -0.47$ -0.78
Weighted Average Shares Outstanding
34.36M 33.67M 33.48M 33.09M 33.09M
Weighted Average Shares Outstanding (Diluted)
34.36M 33.67M 33.48M 33.09M 33.09M
Currency in USD

MiNK Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis